BCO Form 4: EVP Daniel Castillo Receives 50.86 Deferred Units
Rhea-AI Filing Summary
Insider award of program units under deferred compensation plan — The Brink's Company reported that EVP Daniel J. Castillo was credited with 50.86 Program Units under the Key Employees' Deferral Compensation Program on 08/29/2025. Each Program Unit is the economic equivalent of one share of BCO common stock and will settle one-for-one into common stock either when Mr. Castillo leaves the company or on a future date he selected in his deferral election.
The filing notes Program Units are credited monthly based on compensation deferred and any matching amounts, and the units credited on the transaction date were calculated using a share price of $112.04 (the closing price on the final trading day of the month). The report was signed by an attorney-in-fact on behalf of the reporting person.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine deferred-compensation credit to an executive; modest share-equivalent issuance based on monthly deferrals.
The filing documents a non-discretionary credit of 50.86 Program Units to EVP Daniel J. Castillo under the company's Key Employees' Deferral Compensation Program. These units are not immediate stock but are economically equivalent and convert one-for-one into common shares upon specified distribution events. The units were priced using the month's closing share price of $112.04. This is a compensation accounting and governance disclosure rather than an operational or market-moving corporate event; its direct impact on share count and dilution appears immaterial based on the reported quantity.
TL;DR: Disclosure aligns with Section 16 requirements and describes standard plan mechanics; no governance red flags.
The Form 4 clearly identifies the reporting person, relationship (EVP), the plan mechanism, conversion mechanics, and valuation basis for the credited Program Units. It specifies monthly crediting procedures and the distribution triggers available under the deferral election. The filing appears complete for the reported transaction and shows use of an attorney-in-fact signature, which is properly documented. There is no indication of accelerated vesting, option exercise, or other atypical governance actions disclosed here.